Details for New Drug Application (NDA): 040295
✉ Email this page to a colleague
NDA 040295 describes HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE, which is a drug marketed by Actavis Elizabeth, Avanthi Inc, and Novel Labs Inc, and is included in three NDAs. It is available from three suppliers. Additional details are available on the HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE profile page.
The generic ingredient in HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE is homatropine methylbromide; hydrocodone bitartrate. There are five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the homatropine methylbromide; hydrocodone bitartrate profile page.
The generic ingredient in HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE is homatropine methylbromide; hydrocodone bitartrate. There are five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the homatropine methylbromide; hydrocodone bitartrate profile page.
Summary for 040295
| Tradename: | HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE |
| Applicant: | Actavis Elizabeth |
| Ingredient: | homatropine methylbromide; hydrocodone bitartrate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 1.5MG;5MG | ||||
| Approval Date: | Dec 1, 2000 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
